Company Summary
Search
Home Page
 
Vanc Pharmaceuticals Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
June 30TradingN
Board of Directors
NamePosition
Eugene Beukman  Director and Corporate Secretary
  Secretary of the Board
Jamie A. Lewin  Director of the Board
Michael Bianco  Director of the Board
Not Applicable (None)  President
Sina Pirooz  Director of the Board
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
30/May/2000  Canada British Columbia  
Exchange Filing Office
Location
Vancouver Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Developing, manufacturing and selling infection control products  (not available) 
Securities
SymbolSecurity NameMarketStatus
NPHVanc Pharmaceuticals Inc.TSX VentureTRADING
Name HistoryFromTo
Vanc Pharmaceuticals Inc.7/Aug/2014Present
Company Facts Reconciliation
SubjectDate Returned
Summer 2013 CFRNot Received
Associations
Auditing Firm:  Meyers Norris Penny LLP
Subsidiary:  Nuva Marine Pharmaceuticals Corp.
Transfer Agent:  Computershare Investor Services Inc.
Latest Information
TypeDateTitle
News Releases  7/Aug/2014  NEWS RELEASE - COMPANY UPDATE[MARKET NEWS]
    NEWS RELEASE - NAME CHANGE[MARKET NEWS]
    NEWS RELEASE - COMPANY UPDATE[MARKET NEWS]
Bulletins  6/Aug/2014  Name Change
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data